Cargando…

Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial

INTRODUCTION: Patients with amnesic mild cognitive impairment (aMCI) are more likely to develop Alzheimer disease than corresponding age normal population. Because Alzheimer disease is irreversible, early intervention for aMCI patients seems important and urgent. We have designed a pilot multicenter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiayu, Kuang, Xu, Tang, Chunzhi, Xu, Nenggui, Xiao, Songhua, Xiao, Lingjun, Wang, Shengwen, Dong, Yu, Lu, Liming, Zhang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601273/
https://www.ncbi.nlm.nih.gov/pubmed/34797294
http://dx.doi.org/10.1097/MD.0000000000027686
_version_ 1784601308264660992
author Zhang, Jiayu
Kuang, Xu
Tang, Chunzhi
Xu, Nenggui
Xiao, Songhua
Xiao, Lingjun
Wang, Shengwen
Dong, Yu
Lu, Liming
Zhang, Liang
author_facet Zhang, Jiayu
Kuang, Xu
Tang, Chunzhi
Xu, Nenggui
Xiao, Songhua
Xiao, Lingjun
Wang, Shengwen
Dong, Yu
Lu, Liming
Zhang, Liang
author_sort Zhang, Jiayu
collection PubMed
description INTRODUCTION: Patients with amnesic mild cognitive impairment (aMCI) are more likely to develop Alzheimer disease than corresponding age normal population. Because Alzheimer disease is irreversible, early intervention for aMCI patients seems important and urgent. We have designed a pilot multicenter, randomized, parallel controlled trial to assess the efficacy and safety of acupuncture on aMCI, explore the feasibility of acupuncture in the treatment of aMCI, so as to provide a reference for large-sample clinical trials in the next stage. METHOD: We designed a pilot multicenter, randomized, parallel controlled trial. This trial aims to test the feasibility of carrying out a large-sample clinical trial. In this trial, 50 eligible patients with aMCI will be included and allocated to acupuncture group (n = 25) or sham acupuncture group (n = 25) at random. Subjects will accept treatment 2 times a week for 12 weeks continuously, with a total of 24 treatment sessions. We will select 6 acupoints (GV20, GV14, bilateral BL18, bilateral BL23). For the clinical outcomes, the primary outcome is Montreal cognitive assessment, which will be assessed from baseline to the end of this trial. And the secondary outcomes are Mini-mental State Examination, Delayed Story Recall, Clinical Dementia Rating scale, Global Deterioration Scale, Activity of Daily Life, Alzheimer Disease Assessment Scale-Cognitive Section, brain magnetic resonance imaging, brain functional magnetic resonance imaging, and event-related potential P300, which will be assessed before and after treatment. In addition, we will assess the safety outcomes from baseline to the end of this trial and feasibility outcome after treatment. We will evaluate neuropsychological assessment scale (Montreal cognitive assessment, Mini-mental State Examination, Alzheimer Disease Assessment Scale-Cognitive Section) at 3 months and 6 months after treatment. DISCUSSION: This pilot trial aims to explore the feasibility of the trial, verify essential information of its efficacy and safety. This pilot study will provide a preliminary basis for carrying out a larger clinical trial of acupuncture on aMCI in near future.
format Online
Article
Text
id pubmed-8601273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86012732021-11-20 Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial Zhang, Jiayu Kuang, Xu Tang, Chunzhi Xu, Nenggui Xiao, Songhua Xiao, Lingjun Wang, Shengwen Dong, Yu Lu, Liming Zhang, Liang Medicine (Baltimore) 5300 INTRODUCTION: Patients with amnesic mild cognitive impairment (aMCI) are more likely to develop Alzheimer disease than corresponding age normal population. Because Alzheimer disease is irreversible, early intervention for aMCI patients seems important and urgent. We have designed a pilot multicenter, randomized, parallel controlled trial to assess the efficacy and safety of acupuncture on aMCI, explore the feasibility of acupuncture in the treatment of aMCI, so as to provide a reference for large-sample clinical trials in the next stage. METHOD: We designed a pilot multicenter, randomized, parallel controlled trial. This trial aims to test the feasibility of carrying out a large-sample clinical trial. In this trial, 50 eligible patients with aMCI will be included and allocated to acupuncture group (n = 25) or sham acupuncture group (n = 25) at random. Subjects will accept treatment 2 times a week for 12 weeks continuously, with a total of 24 treatment sessions. We will select 6 acupoints (GV20, GV14, bilateral BL18, bilateral BL23). For the clinical outcomes, the primary outcome is Montreal cognitive assessment, which will be assessed from baseline to the end of this trial. And the secondary outcomes are Mini-mental State Examination, Delayed Story Recall, Clinical Dementia Rating scale, Global Deterioration Scale, Activity of Daily Life, Alzheimer Disease Assessment Scale-Cognitive Section, brain magnetic resonance imaging, brain functional magnetic resonance imaging, and event-related potential P300, which will be assessed before and after treatment. In addition, we will assess the safety outcomes from baseline to the end of this trial and feasibility outcome after treatment. We will evaluate neuropsychological assessment scale (Montreal cognitive assessment, Mini-mental State Examination, Alzheimer Disease Assessment Scale-Cognitive Section) at 3 months and 6 months after treatment. DISCUSSION: This pilot trial aims to explore the feasibility of the trial, verify essential information of its efficacy and safety. This pilot study will provide a preliminary basis for carrying out a larger clinical trial of acupuncture on aMCI in near future. Lippincott Williams & Wilkins 2021-11-19 /pmc/articles/PMC8601273/ /pubmed/34797294 http://dx.doi.org/10.1097/MD.0000000000027686 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 5300
Zhang, Jiayu
Kuang, Xu
Tang, Chunzhi
Xu, Nenggui
Xiao, Songhua
Xiao, Lingjun
Wang, Shengwen
Dong, Yu
Lu, Liming
Zhang, Liang
Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial
title Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial
title_full Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial
title_fullStr Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial
title_full_unstemmed Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial
title_short Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial
title_sort acupuncture for amnestic mild cognitive impairment: a pilot multicenter, randomized, parallel controlled trial
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601273/
https://www.ncbi.nlm.nih.gov/pubmed/34797294
http://dx.doi.org/10.1097/MD.0000000000027686
work_keys_str_mv AT zhangjiayu acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT kuangxu acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT tangchunzhi acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT xunenggui acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT xiaosonghua acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT xiaolingjun acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT wangshengwen acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT dongyu acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT luliming acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial
AT zhangliang acupunctureforamnesticmildcognitiveimpairmentapilotmulticenterrandomizedparallelcontrolledtrial